London-based Tiziana Life Sciences PLC is planning a U.S. IPO of its American depositary shares.

The biotechnology company has applied to list its ADSs, representing ordinary shares, on the Nasdaq Capital Market under the symbol TLSA.

Tiziana said its shares will continue to trade on the AIM, a market of the London Stock Exchange.

The company said the offering will be priced at a later date.

Laidlaw & Company (UK) Ltd. is acting as the representative of the underwriters in the offering.